Heike Puschel
Overview
Explore the profile of Heike Puschel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flury-Sutter S, Heuzeroth F, Arbelaez E, Bubendorf L, Puschel H, Hayoz S, et al.
Can Urol Assoc J
. 2024 Mar;
18(7):E233-E239.
PMID: 38466867
Introduction: Little is known about the efficacy and tolerability of intravesical bacillus Calmette-Guérin (BCG) strain Russia for treatment of non-muscle-invasive bladder cancer (NMIBC) in a middle-European population. Methods: A prospective...
2.
Elyan A, Saba K, Sigle A, Wetterauer C, Engesser C, Puschel H, et al.
Eur Urol Focus
. 2023 Oct;
10(4):620-626.
PMID: 37813730
Background: It has been shown that the Stockholm3 test decreases overdetection of prostate cancer (PCa) while retaining the ability to detect clinically significant PCa (csPCa) in a Swedish population. However,...
3.
Rentsch C, Thalmann G, Lucca I, Kwiatkowski M, Wirth G, Strebel R, et al.
Eur Urol Oncol
. 2022 Jan;
5(2):195-202.
PMID: 35012889
Background: VPM1002BC is a genetically modified Mycobacterium bovis bacillus Calmette-Guérin (BCG) strain with potentially improved immunogenicity and attenuation. Objective: To report on the efficacy, safety, tolerability and quality of life...
4.
Rentsch C, Bosshard P, Mayor G, Rieken M, Puschel H, Wirth G, et al.
Oncoimmunology
. 2020 May;
9(1):1748981.
PMID: 32363120
: VPM1002BC is a modified mycobacterium Bacillus Calmette Guérin (BCG) for the treatment of non-muscle invasive bladder cancer (NMIBC). The genetic modifications are expected to result in better immunogenicity and...
5.
Hench I, Cathomas R, Costa L, Fischer N, Gillessen S, Hench J, et al.
Cancers (Basel)
. 2019 Aug;
11(8).
PMID: 31374981
Despite several treatment options and an initial high response rate to androgen deprivation therapy, the majority of prostate cancers will eventually become castration-resistant in the metastatic stage (mCRPC). Androgen receptor...
6.
Guo S, Muller G, Lehmann K, Talimi S, Bonkat G, Puschel H, et al.
Lasers Med Sci
. 2015 Feb;
30(3):1147-51.
PMID: 25698433
This study aims to compare long-term results of photoselective vaporization of the prostate (PVP) with an 80-W potassium titanyl phosphate (KTP) laser and monopolar transurethral resection of the prostate (TURP)...
7.
Vlajnic T, Oeggerli M, Rentsch C, Puschel H, Zellweger T, Thalmann G, et al.
Virchows Arch
. 2014 Oct;
465(6):637-42.
PMID: 25323812
Procurement of fresh tissue of prostate cancer is critical for biobanking and generation of xenograft models as an important preclinical step towards new therapeutic strategies in advanced prostate cancer. However,...
8.
Guo S, Muller G, Bonkat G, Puschel H, Gasser T, Bachmann A, et al.
J Endourol
. 2014 Oct;
29(4):449-54.
PMID: 25290572
Background And Objective: Laser vaporization of the prostate is one of the alternatives to transurethral resection of the prostate. Short-term studies report a comparable outcome after laser vaporization with the...
9.
Muller G, Bonkat G, Rieken M, Wyler S, Bubendorf L, Puschel H, et al.
Urology
. 2013 Feb;
81(4):837-42.
PMID: 23395126
Objective: To compare the performance of the Epstein criteria and the Prostate Cancer Research International: Active Surveillance (PRIAS) criteria in the identification of patients eligible for active surveillance (AS) but...
10.
Rieken M, Bonkat G, Muller G, Wyler S, Ebinger Mundorff N, Puschel H, et al.
Lasers Surg Med
. 2013 Jan;
45(1):28-33.
PMID: 23280439
Background And Objective: Preclinical studies suggest an increased vaporization rate and speed of the 532 nm 180-W XPS GreenLight laser (180-W) compared with the 120-W HPS GreenLight laser (120-W) and...